Leriglitazone-d4, CAS [[1188263-49-1]] Preis auf Anfrage

Catalog Number: MCE-HY-117727S
Article Name: Leriglitazone-d4, CAS [[1188263-49-1]] Preis auf Anfrage
Biozol Catalog Number: MCE-HY-117727S
Supplier Catalog Number: HY-117727S
Alternative Catalog Number: MCE-HY-117727S-1MG
Manufacturer: MedchemExpress
Category: Biochemikalien
Alternative Names: MIN-102-d4, Hydroxypioglitazone-d4
Leriglitazone-d4 (MIN-102-d4, Hydroxypioglitazone-d4) is deuterium labeled Leriglitazone. Leriglitazone is an orally active and a BBB-penetrable PPARgamma agonist with an EC50 of 9 µM. Leriglitazone, as a regulator of mitochondrial function, has neuroprotective, anti-inflammatory and antioxidant effects. Leriglitazone can be used in the study of neuroinflammatory and neurodegenerative diseases[1][2].
Molecular Weight: 376.46
CAS Number: [1188263-49-1]
Formula: C19H16D4N2O4S
Target: Isotope-Labeled Compounds,PPAR
Application Notes: MCE Product type: Isotope-Labeled Compounds